Angiogenic Factors in Laryngeal Carcinomas: Do They Have Prognostic Relevance?
- 1 January 1999
- journal article
- Published by Taylor & Francis in Acta Oto-Laryngologica
- Vol. 119 (2) , 289-292
- https://doi.org/10.1080/00016489950181846
Abstract
Angiogenesis is a cascade-like mechanism essential for tumour growth and metastasis. Recently developed inhibitors of angiogenesis have already proven their benefit in anticancer treatment. Therefore the existence of angiogenic molecules in individual tumours is of major interest. The factors most frequently contributing to angiogenesis are basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF) and some matrix metalloproteinases (MMPs). In order to evaluate the prognostic significance of these molecules we investigated the distribution pattern of VEGF, bFGF, MMP-2 and MMP-9 in 41 laryngeal carcinomas using immunohistochemical methods. The results were correlated with clinicopathological parameters, i.e. T and N stage, histological grading, freedom from disease, overall survival and microvessel density (MVD). Only VEGF revealed a correlation with MVD (p = 0.01) and a weak association with histological grading (p = 0.06). Even though there is controversy about published data on the prognostic relevance of angiogenic factors, our results suggest that the factors examined in this study are not suitable for prognosis in larynx cancer patients.Keywords
This publication has 13 references indexed in Scilit:
- Inhibitors of Angiogenesis Enter Phase III TestingJNCI Journal of the National Cancer Institute, 1998
- Tumoural vascularity as a prognostic factor in cancer patients: the evidence continues to growThe Journal of Pathology, 1998
- CLINICAL RESEARCH ON ANTIANGIOGENIC THERAPYPharmacological Research, 1998
- Independent Prognostic Factors in Breast Cancer PatientsThe American Journal of Surgery, 1998
- Expression of basic fibroblast growth factor and its receptors by head and neck squamous carcinoma tumor and vascular endothelial cellsThe American Journal of Surgery, 1997
- Tumor angiogenesis as a prognostic factor in laryngeal cancerThe American Journal of Surgery, 1997
- Matrix Metalloproteinase Inhibition as a Novel Anticancer Strategy: A Review with Special Focus on Batimastat and MarimastatPharmacology & Therapeutics, 1997
- Expression of matrix metalloproteinase-3 in stage I and II squamous cell carcinoma of the oral cavityJournal of Oral and Maxillofacial Surgery, 1995
- Increased expression of basic fibroblast growth factor in squamous carcinogenesis of the head and neck is less prevalent following smoking cessationThe American Journal of Surgery, 1994
- Tumor Angiogenesis: A New Significant and Independent Prognostic Indicator in Early-Stage Breast CarcinomaJNCI Journal of the National Cancer Institute, 1992